top of page

Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB


Warren Buffett’s Hiring Rule: Why Integrity Comes First
Warren Buffett’s hiring philosophy has long been quoted in business circles, and for good reason. As he prepares to step down as CEO of...


Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...


The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Search
NeuroBo Pharmaceuticals Welcomes Hyung Heon Kim as New CEO and President
Boston, MA, August 14, 2023 (PRNewswire) -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology firm dedicated...
Neuralink Rockets Forward with $280M Funding Boost
Fremont, CA, August 7, 2023 (Reuters) -- Neuralink, the cerebral implant venture founded by Elon Musk, has successfully secured $280...
Nexo Therapeutics Emerges from Steath with $60M Series A Financing
Watertown, MA, and Golden, CO, July 26, 2023 (Business Wire) -- Nexo Therapeutics has made an entrance into the spotlight with an...
VivoSense Announces Colin Bower as CEO
Newport Coast, CA, August 2, 2023 (Business Wire) -- VivoSense, Inc. ("VivoSense") is delighted to introduce Colin Bower as their new...
Kriya's Series C Surges to Over $430 Million
Palo Alto, CA, and Research Triangle Park, NC, July 26, 2023 (Globe Newswire) -- Kriya Therapeutics, Inc., a biopharmaceutical company...
TheracosBio Welcomes Brian Connelly as New Chief Executive Officer
Marlborough, MA, August 1, 2023 (Business Wire) -- TheracosBio, a trailblazer in the biopharmaceutical industry, appointed Brian...
Biogen's $6.5B Acquisition of Reata: Powering Up Rare Disease Portfolio!
Cambridge, MA, July 28, 2023 (Reuters) -- Biogen (BIIB.O) has announced that it is acquiring Reata Pharmaceuticals (RETA.O), for almost...
Septerna Raises $150M in Series B Financing to Advance Novel GPCR Medicines
South San Francisco, CA, July 11, 2023 (Business Wire) -- Biotech firm Septerna secures $150 million in a Series B funding round to...
CurvaFix Appoints New CEO Mark Foster
Bellevue, WA, July 14, 2023 (Business Wire) -- CurvaFix, a groundbreaking medical device developer specializing in curved bone fracture...
Mirum Pharmaceuticals to Acquire Travere's Bile Acid Product Portfolio for $445M
Foster City, CA, July 17, 2023 (Business Wire) -- Mirum Pharmaceuticals and Travere Therapeutics have finalized a deal for the sale of...
Neumora Therapeutics Appoints Henry Gosebruch as CEO to Lead Neuroscience Revolution
Watertown, MA, July 18, 2023 (Business Wire) -- Neumora Therapeutics, a biopharmaceutical company focused on transforming neuroscience...
Argenx Raises $1.1B in Global Offering for Immunology Advancements
Amsterdam, Netherlands, July 19, 2023 (Globe Newswire) -- Argenx, a global immunology company, has priced a global offering to...
bottom of page

